EP3139935A4 - Therapeutische plazentale zusammensetzungen, verfahren zur herstellung und verfahren zur verwendung - Google Patents

Therapeutische plazentale zusammensetzungen, verfahren zur herstellung und verfahren zur verwendung Download PDF

Info

Publication number
EP3139935A4
EP3139935A4 EP14891336.1A EP14891336A EP3139935A4 EP 3139935 A4 EP3139935 A4 EP 3139935A4 EP 14891336 A EP14891336 A EP 14891336A EP 3139935 A4 EP3139935 A4 EP 3139935A4
Authority
EP
European Patent Office
Prior art keywords
methods
making
placental compositions
therapeutic placental
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14891336.1A
Other languages
English (en)
French (fr)
Other versions
EP3139935A1 (de
Inventor
Timothy Jansen
Samson Tom
Alla Danilkovitch
Dana Yoo
Jaime Zerhusen
Gabriele Putz TODD
Amy Elizabeth Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osiris Therapeutics Inc
Original Assignee
Osiris Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osiris Therapeutics Inc filed Critical Osiris Therapeutics Inc
Publication of EP3139935A1 publication Critical patent/EP3139935A1/de
Publication of EP3139935A4 publication Critical patent/EP3139935A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP14891336.1A 2014-05-07 2014-05-07 Therapeutische plazentale zusammensetzungen, verfahren zur herstellung und verfahren zur verwendung Withdrawn EP3139935A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2014/037201 WO2015171142A1 (en) 2014-05-07 2014-05-07 Therapeutic placental compositions, methods of making and methods of use

Publications (2)

Publication Number Publication Date
EP3139935A1 EP3139935A1 (de) 2017-03-15
EP3139935A4 true EP3139935A4 (de) 2017-11-15

Family

ID=54392804

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14891336.1A Withdrawn EP3139935A4 (de) 2014-05-07 2014-05-07 Therapeutische plazentale zusammensetzungen, verfahren zur herstellung und verfahren zur verwendung

Country Status (7)

Country Link
EP (1) EP3139935A4 (de)
JP (1) JP2017514876A (de)
KR (1) KR20160147058A (de)
AU (1) AU2014393402A1 (de)
CA (1) CA2948126A1 (de)
SG (1) SG11201609254YA (de)
WO (1) WO2015171142A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3351624B1 (de) 2010-02-18 2022-09-14 Osiris Therapeutics, Inc. Verfahren zur herstellung therapeutischer produkte mit vitalisierten plazentadispersionen
JP7011135B2 (ja) * 2016-02-19 2022-02-10 佳秀工業株式会社 血管内皮増殖因子産生促進剤の製造方法及び発毛剤の製造方法、並びに血管内皮増殖因子産生促進剤及び発毛剤
CN109069867B (zh) 2016-03-14 2022-02-01 无痛疗法股份有限公司 无细胞胎盘制剂
WO2017165698A1 (en) * 2016-03-23 2017-09-28 Mimedx Group, Inc. Compositions and methods of treatment with amniotic fluid
CA3032160C (en) 2016-08-24 2024-05-28 Arthrex, Inc. Tissue hybrid for use in repairing, reconstructing or regenerating musculoskeletal degenerative processes or injuries
US10960028B2 (en) 2017-02-01 2021-03-30 Plakous Therapeutics, Inc. Placental tissue compositions
US11511017B2 (en) 2019-03-12 2022-11-29 Arthrex, Inc. Ligament reconstruction
WO2021003257A1 (en) * 2019-07-01 2021-01-07 Auxocell Laboratories, Inc. Methods and compositions for collecting and using placental tissue cells and placental blood cells
AU2020386363A1 (en) * 2019-11-21 2022-05-19 Bioventus, Llc . Placental tissue particulate compositions and methods of use
WO2021123320A1 (en) * 2019-12-20 2021-06-24 Dr. Kalali Prof. Mostafazadeh Dipl. Ing. Miedl (Kmm) Gesellschaft Bürgerlichen Rechts A composition and its use for a universal therapy against tumor cells
KR102116954B1 (ko) * 2019-12-26 2020-05-29 주식회사 엠케이바이오텍 태아 유래 줄기세포의 동결 보존 및 동결 건조용 배지 조성물
EP4135729A4 (de) * 2020-04-17 2024-07-31 Crown Scient L L C Regenerative nichtsteroidale entzündungshemmende zusammensetzungen, verfahren zur herstellung und verfahren zur verwendung davon
WO2022074523A1 (en) * 2020-10-06 2022-04-14 Osiris Therapeutics, Inc. Primed placental tissue and uses in regenerative medicine
JP2024509124A (ja) * 2021-02-26 2024-02-29 アルグラ サイエンシズ エルエルシー 絨毛間質細胞組成物及びその使用
WO2023192484A2 (en) * 2022-04-01 2023-10-05 Bright Cell, Inc. A mesenchymal stem cells formulation for cosmetic use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009120996A1 (en) * 2008-03-27 2009-10-01 Biolife Solutions, Inc. Mehtod, system, and apparatus for hypothermic collection, storage, transport and banking of birth tissue
EP2702871A1 (de) * 2002-03-26 2014-03-05 Anthrogenesis Corporation Kollagenbiogewebe und Verfahren zur Herstellung und Verwendung davon
US20140106447A1 (en) * 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60143514D1 (de) * 2000-02-11 2011-01-05 Gen Hospital Corp Photochemische gewebeverbindung
EP1641913B1 (de) * 2003-06-27 2016-01-06 DePuy Synthes Products, Inc. Aus der nabelschnur abgeleitete postpartum zellen und deren herstellungsmethoden und verwendung
EP3351624B1 (de) * 2010-02-18 2022-09-14 Osiris Therapeutics, Inc. Verfahren zur herstellung therapeutischer produkte mit vitalisierten plazentadispersionen
US8632512B2 (en) * 2010-04-09 2014-01-21 Kci Licensing, Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2702871A1 (de) * 2002-03-26 2014-03-05 Anthrogenesis Corporation Kollagenbiogewebe und Verfahren zur Herstellung und Verwendung davon
WO2009120996A1 (en) * 2008-03-27 2009-10-01 Biolife Solutions, Inc. Mehtod, system, and apparatus for hypothermic collection, storage, transport and banking of birth tissue
US20140106447A1 (en) * 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JI SUK CHOI ET AL: "Full-Thickness Skin Wound Healing Using Human Placenta-Derived Extracellular Matrix Containing Bioactive Molecules", TISSUE ENGINEERING PART A, vol. 19, no. 3-4, 1 February 2013 (2013-02-01), pages 329 - 339, XP055395217, ISSN: 1937-3341, DOI: 10.1089/ten.tea.2011.0738 *

Also Published As

Publication number Publication date
JP2017514876A (ja) 2017-06-08
SG11201609254YA (en) 2016-12-29
WO2015171142A1 (en) 2015-11-12
AU2014393402A1 (en) 2016-11-24
EP3139935A1 (de) 2017-03-15
KR20160147058A (ko) 2016-12-21
CA2948126A1 (en) 2015-11-12

Similar Documents

Publication Publication Date Title
HK1254525A1 (zh) 治療組合物、組合和使用方法
EP3245291A4 (de) Neuartige mikrodystrophine und zugehörige verfahren zur verwendung
EP3242672A4 (de) Amnionderivierte therapeutische zusammensetzung und verfahren zur herstellung davon
EP3139935A4 (de) Therapeutische plazentale zusammensetzungen, verfahren zur herstellung und verfahren zur verwendung
EP3347469A4 (de) Verfahren und zusammensetzungen zur behandlung von glaukom
EP3199628A4 (de) Zytotoxizitätsinduzierendes therapeutikum
EP3160470A4 (de) Analoga aus pridopidin, deren herstellung und verwendung
EP3204386A4 (de) Substituierte aminopurinverbindungen, zusammensetzungen davon und behandlungsverfahren damit
EP3102200A4 (de) Therapeutische verbindungen und zusammensetzungen
EP3104948A4 (de) Spielzeug zur sensorischen stimulation mit eltern-kleinkind-interaktion und verfahren zur verwendung
HK1259372A1 (zh) 治療化合物、其組合物及使用方法
EP3139928A4 (de) Anordrin-zusammensetzungen und verfahren zur behandlung von krankheiten
EP3194564A4 (de) Trichodermazusammensetzungen und verfahren zur verwendung
EP3094606A4 (de) Zementzusammensetzungen, strukturen und verfahren zur verwendung
EP3265096A4 (de) Ophthalmische zusammensetzungen und verfahren zur verwendung davon
EP3125963A4 (de) Gewebefüllerzusammensetzungen und verfahren zur verwendung
EP3224362A4 (de) Therapeutische zusammensetzungen mit transkriptionsfaktoren sowie verfahren zur herstellung und verwendung davon
EP3136879A4 (de) Konzentrierte proteinzusammensetzungen und verfahren zu deren herstellung
EP3117827A4 (de) Zusammensetzung für die vagina und verwendung der zusammensetzung
EP3110446A4 (de) Verfahren und zusammensetzungen zur behandlung von siglec-8-assoziierten krankheiten
EP3190886A4 (de) Zusammensetzung und verfahren zur verwendung davon
EP3436467A4 (de) Neuartige zusammensetzungen und therapeutische verfahren
EP3247365A4 (de) Neuartige jodophorzusammensetzung und verfahren zur verwendung
EP3183243A4 (de) Organotellurverbindungen, zusammensetzungen und verfahren zur verwendung davon
EP3297619A4 (de) Therapeutische verwendung von l-4-chlorokynurenin

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20161118

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20171013

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/50 20150101AFI20171009BHEP

Ipc: A61P 17/02 20060101ALI20171009BHEP

17Q First examination report despatched

Effective date: 20180702

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20181113